ImmunoGen’s Elahere Support Services
ImmunoGen offers Elahere Support Services to support patients who have been prescribed Elahere (Table).
Elahere Support Services
Elahere Support Services is committed to helping appropriate patients start on Elahere by offering access and reimbursement support, as well as affordability assistance. Once enrolled, an Elahere Support Services case manager will help the patient understand their insurance coverage and navigate financial assistance options, including a Copay Assistance Program and a Patient Assistance Program.
Patients eligible for the Copay Assistance Program could pay as little $0 for their medication
For more information on Elahere Support Services, please call 833-352-4373. To enroll your patient in Elahere Support Services, visit Elahere Enroll.
TABLE ImmunoGen Oncology Drug
Drugs
Indications
Patient support programs
Drug
Elahere (mirvetuximab soravtansine-gynx)
Indications
Treatment of adult patients with folate receptor–alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received 1 to 3 prior systemic treatment regimens; select patients for therapy based on an FDA-approved test
Patient support program